Capital Investment Advisory Services, LLC Amgen Inc Transaction History

Capital Investment Advisory Services, LLC

$1.04 Billion
Q1 2025

A detailed history of Capital Investment Advisory Services, LLC transactions in Amgen Inc stock. As of the latest transaction made, Capital Investment Advisory Services, LLC holds 10,515 shares of AMGN stock, worth $2.94 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

10,515

Previous 10,026 4.88%

Holding current value

$2.94 Million

Previous $2.61 Million 25.33%

% of portfolio

0.32%

Previous 0.27%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 29, 2025	BUY	$258.59 - $327.36 $126,450 - $160,079	489 Added 4.88%	10,515 $3.28 Million
Q4 2024 Jan 23, 2025	BUY	$258.78 - $328.31 $40,628 - $51,544	157 Added 1.59%	10,026 $2.61 Million
Q3 2024 Oct 30, 2024	SELL	$309.38 - $337.38 $382,393 - $417,001	-1,236 Reduced 11.13%	9,869 $3.18 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $109,829 - $133,471	418 Added 3.91%	11,105 $3.47 Million
Q1 2024 Apr 25, 2024	SELL	$268.87 - $324.56 $322,912 - $389,796	-1,201 Reduced 10.1%	10,687 $3.04 Million
Q4 2023 Feb 01, 2024	SELL	$255.7 - $288.46 $37,332 - $42,115	-146 Reduced 1.21%	11,888 $3.42 Million
Q3 2023 Nov 02, 2023	SELL	$218.65 - $271.46 $1,749 - $2,171	-8 Reduced 0.07%	12,034 $3.23 Million
Q2 2023 Jul 28, 2023	BUY	$214.27 - $253.37 $417,826 - $494,071	1,950 Added 19.32%	12,042 $2.67 Million
Q1 2023 Apr 21, 2023	BUY	$225.79 - $275.2 $16,934 - $20,640	75 Added 0.75%	10,092 $2.44 Million
Q4 2022 Feb 03, 2023	BUY	$229.03 - $291.01 $251,245 - $319,237	1,097 Added 12.3%	10,017 $2.63 Million
Q3 2022 Oct 26, 2022	SELL	$224.46 - $253.15 $9,202 - $10,379	-41 Reduced 0.46%	8,920 $2.01 Million
Q2 2022 Jul 22, 2022	SELL	$230.71 - $256.74 $34,837 - $38,767	-151 Reduced 1.66%	8,961 $2.18 Million
Q1 2022 May 03, 2022	SELL	$219.27 - $242.57 $5,701 - $6,306	-26 Reduced 0.28%	9,112 $2.2 Million
Q4 2021 Feb 01, 2022	BUY	$198.88 - $227.6 $97,252 - $111,296	489 Added 5.65%	9,138 $2.06 Million
Q3 2021 Oct 28, 2021	BUY	$212.27 - $248.7 $25,047 - $29,346	118 Added 1.38%	8,649 $1.84 Million
Q2 2021 Jul 27, 2021	SELL	$233.58 - $259.14 $11,912 - $13,216	-51 Reduced 0.59%	8,531 $2.08 Million
Q1 2021 May 05, 2021	SELL	$221.91 - $258.6 $39,499 - $46,030	-178 Reduced 2.03%	8,582 $2.14 Million
Q4 2020 Jan 25, 2021	BUY	$216.38 - $257.67 $291,031 - $346,566	1,345 Added 18.14%	8,760 $2.01 Million
Q3 2020 Oct 19, 2020	BUY	$234.65 - $260.95 $99,491 - $110,642	424 Added 6.06%	7,415 $1.89 Million
Q2 2020 Aug 05, 2020	BUY	$197.81 - $242.74 $5,143 - $6,311	26 Added 0.37%	6,991 $1.65 Million
Q1 2020 Apr 28, 2020	SELL	$182.24 - $241.7 $79,821 - $105,864	-438 Reduced 5.92%	6,965 $1.41 Million
Q4 2019 Feb 04, 2020	SELL	$189.21 - $243.2 $10,595 - $13,619	-56 Reduced 0.75%	7,403 $1.79 Million
Q3 2019 Oct 17, 2019	BUY	$174.11 - $208.62 $144,511 - $173,154	830 Added 12.52%	7,459 $1.44 Million
Q2 2019 Aug 08, 2019	BUY	$166.7 - $195.41 $39,841 - $46,702	239 Added 3.74%	6,629 $1.17 Million
Q1 2019 Apr 23, 2019	SELL	$180.87 - $203.88 $70,358 - $79,309	-389 Reduced 5.74%	6,390 $1.21 Million
Q4 2018 Feb 04, 2019	SELL	$178.4 - $208.25 $13,201 - $15,410	-74 Reduced 1.08%	6,779 $1.32 Million
Q3 2018 Oct 30, 2018	SELL	$185.29 - $208.89 $30,943 - $34,884	-167 Reduced 2.38%	6,853 $1.42 Million
Q2 2018 Aug 01, 2018	SELL	$166.05 - $186.51 $13,450 - $15,107	-81 Reduced 1.14%	7,020 $1.3 Million
Q1 2018 Apr 30, 2018	BUY	$169.43 - $198.0 $10,504 - $12,276	62 Added 0.88%	7,101 $1.21 Million
Q4 2017 Jan 31, 2018	BUY	$168.79 - $188.59 $14,347 - $16,030	85 Added 1.22%	7,039 $1.22 Million
Q3 2017 Oct 31, 2017	BUY	$167.29 - $191.0 $1.16 Million - $1.33 Million	6,954	6,954 $1.3 Million

Others Institutions Holding AMGN

# of Institutions

3,306

Shares Held

429M

Call Options Held

8.06M

Put Options Held

7.7M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Advisory Services, LLC with notifications on news.

Account

Capital Investment Advisory Services, LLC Amgen Inc Transaction History